[Prognostic value of hyperuricemia in chronic heart failure]

Rev Med Chil. 2004 Sep;132(9):1031-6. doi: 10.4067/s0034-98872004000900002.
[Article in Spanish]

Abstract

Background: Hyperuricemia has been proposed as a risk marker in chronic heart failure, but its value as an independent prognostic is not well established.

Aim: To determine the prognostic value of hyperuricemia, in patients with chronic stable heart failure.

Patients and methods: Forty six male patients with chronic heart failure, aged 62 +/- 13 years, were studied. Their election fraction was less than 40% and their serum creatinine was less than 2 mg/dl. Serum uric acid and catecholamines, maximal oxygen consumption (VO2 max) and left ventricular ejection fraction were measured. Mortality and the need for cardiac transplant were recorded as endpoints during a mean follow up of 39 +/- 18 months. The relationship between basal measures and the occurrence of events was analyzed using univariate and multivariate methods.

Results: Basal VO2 max and left ventricular ejection fraction were 16 +/- 4.6 ml/kg/min and 22 +/- 7% respectively. Eighteen patients died and three required transplantation during the follow up. Patients reaching these endpoints had a lower VO2 max and left ventricular ejection fraction and higher uric acid levels. Multivariate analysis accepted left ventricular ejection fraction (relative risk 0.89, 95% CI 0.82-0.97) and serum uric acid (relative risk 1.335 95% CI 1.02-1.74) as significant predictors of events. The relative risk for cardiac transplantation was 7.07 times higher among those with a serum uric acid over 7 mg/dl.

Conclusions: A high serum uric acid is an independent predictor of bad prognosis in patients with stable chronic heart failure.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Analysis of Variance
  • Biomarkers / blood
  • Chronic Disease
  • Creatinine / blood
  • Follow-Up Studies
  • Heart Failure / blood
  • Heart Failure / mortality*
  • Heart Failure / surgery
  • Heart Transplantation*
  • Humans
  • Hyperuricemia / blood
  • Hyperuricemia / complications
  • Hyperuricemia / mortality*
  • Male
  • Middle Aged
  • Prognosis
  • Risk Factors
  • Stroke Volume / physiology

Substances

  • Biomarkers
  • Creatinine